Showing results (361-370 of 410) with videos related to

Sort By:
Pageof 41
International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1996
Estimate criteria for efficacy of treatment in benign prostatic hyperplasiaY Homma, K Kawabe, T Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 1997
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study GroupY Homma, H Akaza, K Okada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 1996
Estimate criteria for diagnosis and severity in benign prostatic hyperplasiaY Homma, K Kawabe, T Tsukamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 1999
Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation. The Prostate Cancer Study GroupY Homma, H Akaza, K Okada, et al.
American Journal of Veterinary Research|December 1, 1976
Effect of common protective antigen vaccination to protect mink from challenge exposure with Pseudomonas aeruginosaT Shimizu, J Y Homma, C Abe, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 10, 2011
Unconventional superconductivity of NpPd(5)Al(2)D Aoki, Y Haga, T D Matsuda, et al.
Journal of the American College of Cardiology|November 25, 2000
Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor responseK Okumura, T Osanai, T Kosugi, et al.
Physical Review Letters|February 7, 2007
NMR evidence for higher-order multipole order parameters in NpO2Y Tokunaga, D Aoki, Y Homma, et al.
Tissue Antigens|April 5, 2012
Associations between six classical HLA loci and rheumatoid arthritis: a comprehensive analysisS Mitsunaga, Y Suzuki, M Kuwana, et al.
Oncogene|June 9, 2016
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growthD Obinata, K Takayama, K Fujiwara, et al.
Pageof 41